ADAR and hepatocellular carcinoma: In addition, Cisplatin treatment of HCC cells led to a decrease of ADAR1 p110 consistent with our previous report that Cisplatin could suppress AR expression,25 whereas Cisplatin failed to do so in AR-negative cells (Figure 2d).